መነሻ › የኤንዶሜትሪየም ካንሰር › ማሳቹሴትስ

በማሳቹሴትስ ለየኤንዶሜትሪየም ካንሰር የሚደረጉ ክሊኒካዊ ጥናቶች

ለየኤንዶሜትሪየም ካንሰር የሚደረጉ 53 ጥናቶች በማሳቹሴትስ ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።

በማሳቹሴትስ ውስጥ ያሉ ከተሞች

Official study text (English)

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Tufts Medical Center, Boston
Dana-Farber Cancer Institute, Boston
Baystate Medical Center, Springfield
እና 1 ተጨማሪ

ተሳታዮችን በመፈለግ ላይደረጃ 2

ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT05564377

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Massachusetts General Hospital, Boston
Dana Farber Cancer Institute, Boston

ተሳታዮችን በመፈለግ ላይደረጃ 1/2

እድሜ 12 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT04585750

Distance-Based Exercise to Preserve Function and Prevent Disability

Dana-Farber Cancer Institute, Boston

ተሳታዮችን በመፈለግ ላይ

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT07059884

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

Dana-Farber Cancer Institute, Boston

ተሳታዮችን በመፈለግ ላይደረጃ 3

እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ2 ኦክቶ 2026 · NCT07198074

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

Dana-Farber Cancer Institute - Oncology Department, Boston

ተሳታዮችን በመፈለግ ላይደረጃ 2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT06760819

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

Dana Farber Cancer Institute, Boston

ተሳታዮችን በመፈለግ ላይደረጃ 1

እድሜ 19 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT06586957

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

Research Site, Boston

ተሳታዮችን በመፈለግ ላይደረጃ 1

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06218914

Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers

Massachusetts General Hospital, Boston
Dana Farber / Harvard Cancer Center, Boston

ተሳታዮችን በመፈለግ ላይደረጃ 1/2

እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT03564340

A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab

Massachusetts General Hospital, Boston
Dana Farber Cancer Institute Brookline Avenue, Boston

ተሳታዮችን በመፈለግ ላይደረጃ 1/2

እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ24 ሴፕቴ 2026 · NCT04590326

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

Massachusetts General Hospital Cancer Center, Boston
Baystate Medical Center, Springfield
UMass Memorial Medical Centre, Worcester

ተሳታዮችን በመፈለግ ላይደረጃ 2

እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ24 ሴፕቴ 2026 · NCT05640999

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Dana Farber Cancer Institute, Boston

ተሳታዮችን በመፈለግ ላይደረጃ 1/2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT06128551

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

Massachusetts General Hospital, Boston
Dana-Farber Cancer Institute, Boston

ተሳታዮችን በመፈለግ ላይደረጃ 1

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07114601

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Massachusetts General Hospital, Boston
Dana-Farber Cancer Institute, Boston

ተሳታዮችን በመፈለግ ላይደረጃ 1

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ21 ሴፕቴ 2026 · NCT05983432

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

Tufts Medical Center ( Site 6052), Boston

ተሳታዮችን በመፈለግ ላይደረጃ 3

እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ17 ሴፕቴ 2026 · NCT06952504

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

Massachusetts General Hospital, Boston

ተሳታዮችን በመፈለግ ላይደረጃ 1/2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ሴፕቴ 2026 · NCT07109726

ALPINE: Maintenance Letrozole/Abemaciclib

Beth Israel Deaconess Medical Center, Boston
Brigham and Women's Hospital, Boston
Dana-Farber Cancer Institute, Boston
እና 1 ተጨማሪ

ተሳታዮችን በመፈለግ ላይደረጃ 2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ16 ሴፕቴ 2026 · NCT06366347

A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies

Research Site, Boston

ተሳታዮችን በመፈለግ ላይደረጃ 1/2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ11 ሴፕቴ 2026 · NCT05123482

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

Dana Farber Cancer Institute, Boston

ተሳታዮችን በመፈለግ ላይደረጃ 1

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ10 ሴፕቴ 2026 · NCT06293898

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

UMass Memorial Medical Ctr, Worcester

ተሳታዮችን በመፈለግ ላይደረጃ 3

እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ9 ሴፕቴ 2026 · NCT07166094

Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.

Dana-Farber Cancer Institute, Boston

ተሳታዮችን በመፈለግ ላይደረጃ 1

እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ3 ሴፕቴ 2026 · NCT07755436

A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors

Dana-Farber Cancer Institute, Boston

ተሳታዮችን በመፈለግ ላይደረጃ 1

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ3 ሴፕቴ 2026 · NCT06515613

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Research Site, Boston

ተሳታዮችን በመፈለግ ላይደረጃ 3

እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ3 ሴፕቴ 2026 · NCT06989112

Concurrent Laparoscopic Hysterectomy and Weight Loss Surgery in Obese Patients With Endometrial Carcinoma or Endometrial Intraepithelial Neoplasia

Brigham and Women's Hospital, Boston
Dana-Farber Cancer Institute, Boston

ተሳታዮችን በመፈለግ ላይ

እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ31 ኦገስ 2026 · NCT04839614

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

Mass General Cancer Center, Boston

ተሳታዮችን በመፈለግ ላይደረጃ 1

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ27 ኦገስ 2026 · NCT07227168

A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors

Dana-Farber Cancer Institute, Boston

ተሳታዮችን በመፈለግ ላይደረጃ 1

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ26 ኦገስ 2026 · NCT07383506

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Dana-Farber Cancer Institute, Boston

ተሳታዮችን በመፈለግ ላይደረጃ 1/2

12 Months – 30 Years · ሁሉም ጾታዎች · የተሻሻለው በ25 ኦገስ 2026 · NCT04851119

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

Dana Farber Cancer Institute, Boston

ተሳታዮችን በመፈለግ ላይደረጃ 1

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ21 ኦገስ 2026 · NCT06774963

Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors

Research Site, Boston

ተሳታዮችን በመፈለግ ላይደረጃ 1/2

እድሜ ከ18 እስከ 130 · ሁሉም ጾታዎች · የተሻሻለው በ21 ኦገስ 2026 · NCT05797168

A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma

Dana Farber Cancer Institute, Boston

ተሳታዮችን በመፈለግ ላይደረጃ 2

እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ21 ኦገስ 2026 · NCT05548296

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

Massachusetts General Hospital, Boston

ተሳታዮችን በመፈለግ ላይደረጃ 1/2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ19 ኦገስ 2026 · NCT04104776

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

Normunity Investigational Site, Boston
Normunity Investigational Site, Boston

ተሳታዮችን በመፈለግ ላይደረጃ 1

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ18 ኦገስ 2026 · NCT07182149

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Massachusetts General Hospital, Boston
Dana Farber Cancer Institute, Boston

ተሳታዮችን በመፈለግ ላይደረጃ 1/2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ኦገስ 2026 · NCT05919264

A Study of PHST001 in Advanced Solid Tumors

Dana Farber Cancer Institute, Boston

ተሳታዮችን በመፈለግ ላይደረጃ 1

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ12 ኦገስ 2026 · NCT06840886

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Massachusetts General Hospital Cancer Center, Boston

ተሳታዮችን በመፈለግ ላይደረጃ 1/2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ11 ኦገስ 2026 · NCT05592626

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Massachusetts General Hospital, Boston
Dana Farber Cancer Institute, Boston

ተሳታዮችን በመፈለግ ላይደረጃ 1/2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ4 ኦገስ 2026 · NCT05579366

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

Massachusetts General Hospital, Boston
Dana-Farber Cancer Institute, Boston

ተሳታዮችን በመፈለግ ላይደረጃ 1/2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ7 ጁላይ 2026 · NCT05768139

A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

Mass General Brigham Cancer Institute at Massachusetts General Hospital, Boston

ተሳታዮችን በመፈለግ ላይደረጃ 1

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ29 ጁን 2026 · NCT07458347

Integrated Cancer Repository for Cancer Research

Holyoke Medical Center, Holyoke

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ

እድሜ ከ19 እስከ 110 · ሁሉም ጾታዎች · የተሻሻለው በ29 ጁን 2026 · NCT02012699

A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors

Beth Israel Deaconess Medical Center, Boston
Dana-Farber Cancer Institute, Boston

ተሳታዮችን በመፈለግ ላይደረጃ 1/2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ29 ጁን 2026 · NCT05377996

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

Beth Israel Deaconess Medical Center, Boston
Dana-Farber Cancer Institute, Boston

ተሳታዮችን በመፈለግ ላይደረጃ 1/2

እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ23 ጁን 2026 · NCT06993844

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።